News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Vertex (VRTX) Terminates Leases on Three Properties in Cambridge, Massachusetts     3/2/2015
Mersana Therapeutics Nabs $35 Million And A New CEO     3/2/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel     3/2/2015
CALBIO15: Gene Therapy in "Second Honeymoon" Phase as Companies, Investors Swarm     3/2/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/2/2015
AstraZeneca PLC (AZN) Chairman Urges Executive Bonuses Be Linked to Sales Goal Pledge     3/2/2015
Baxter International (BAX) Starts Hiring in Anticipation of Planned Drug Spinout Baxalta     3/2/2015
Boston Scientific (BSX) Snags Endo International (ENDP)'s Urology Portfolio in Deal Worth $1.65 Billion     3/2/2015
Cardinal Health (CAH) Ponies Up $1.944 Billion Cash for Johnson & Johnson (JNJ)'s Cordis (JNJ)     3/2/2015
Shares Fall as the FDA Rejects Pacira (PCRX)'s Application for Expanded Use of Pain Drug     3/2/2015
New Jersey Startup Celimmune Aims to Give New Life to Shelved Amgen (AMGN) Drug     3/2/2015
Ousted Sanofi (SAN.PA) CEO Lands Next Gig     2/27/2015
AstraZeneca PLC (AZN) to Carve Out Antibiotic R&D Into New $40 Million Firm; Move Will Impact 95 Employees     2/27/2015
Johnson & Johnson (JNJ) Could Bring 700 High-Paying Jobs to Florida     2/27/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     2/27/2015

News from Around the Web
Britain's Secret Science Powerhouse     3/2/2015
Treadmill Performance Predicts Risk Of Death, Johns Hopkins University Study     3/2/2015
How Pollution May Make You Obese, University of Granada Study     3/2/2015
Your Brain Knows Your Next Move Before You Do, Howard Hughes Medical Institute Study     3/2/2015
Personality And Place: New Insights On Person-Environment Links, Journal Of Personality And Social Psychology Reveals     3/2/2015
How Social Media Can Indicate Personality, Health Risks, And Cultural Differences     3/2/2015
Shake It Off? Not So Easy For People With Depression, University of Michigan Medical School Study     3/2/2015
Autistic Man Who Grew 46DD Breasts Wins $2.5 Million Drug Suit     3/2/2015
Gilead (GILD) Holds Cash Overseas to Save Billions on Taxes     2/27/2015
Decision On Ebola Mass Vaccination In August At Earliest: WHO     2/27/2015
Twin Study Lends New Insights Into Link between Back Pain And Depression, University of Sydney Reveals     2/27/2015
First World War Explosive Could Reverse Diabetes, Yale University Study     2/27/2015
Who's The Most High-Strung?     2/27/2015
Chinese Herb Effective In Treating Ebola, Texas Biomedical Research Institute Study Reveals     2/27/2015
Can Coffee Cut Your MS Risk? Johns Hopkins University Study     2/27/2015

Press Releases
Actavis (ACT) Hormonal Contraceptive Device Wins FDA Approval     3/2/2015
Actavis (ACT) Receives Approval From The European Commission For XYDALBA (dalbavancin)     3/2/2015
Bristol-Myers Squibb (BMY) Release: U.S. FDA Accepts Biologics Licensing Application For Opdivo (Nivolumab) For The Treatment Of Advancedsquamous Non-Small Cell Lung Cancer     3/2/2015
Alexion Pharmaceuticals Inc. (ALXN) Release: FDA Grants Priority Review For Asfotase Alfa As A Treatment For Patients With Hypophosphatasia     3/2/2015
Cardio3 BioSciences Marks First Important Milestone In Regulatory Path Toward C-Cure Market Registration With Paediatric Investigation Plan Waiver From European Medicines Agency     3/2/2015
Celgene International Sárl (CELG) Release: ABRAXANE Approved By European Commission For First-Line Treatment Of Patients With Non-Small Cell Lung Cancer     3/2/2015
Newron Pharmaceuticals (NWRN) Release: Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The FDA     3/2/2015
Pacira Pharmaceuticals, Inc. (PCRX) Receives Complete Response Letter From FDA For sNDA Seeking Approval Of EXPAREL Use In Nerve Block To Provide Postsurgical Analgesia     3/2/2015
Taiho Pharmaceutical Submits TAS-102 Marketing Authorisation Application To The European Medicines Agency For The Treatment Of Refractory Metastatic Colorectal Cancer     3/2/2015
Shire (SHPGY) Submits Application To The U.S. D&A Pharma For Approval Of Lifitegrast For Treatment Of Dry Eye Disease In Adults     3/2/2015
European Medicines Agency Accepts Santen, Inc.'s Marketing Application Filing For Intravitreal Sirolimus For The Treatment Of Noninfectious Uveitis Of The Posterior Segment     3/2/2015
Boehringer Ingelheim Submits Biologics License Application To FDA For Idarucizumab, Investigational Specific Reversal Agent For Pradaxa (Dabigatran Etexilate Mesylate)     3/2/2015
Dynavax Technologies Corporation (DVAX) Announces Second Independent DSMB Recommendation To Continue Phase 3 Study Of HEPLISAV-B     3/2/2015
Otsuka Pharmaceutical Co., Ltd. Release: First-Ever Treatment Approved In Canada For Adults Living With ADPKD, A Life-Threatening Kidney Disease     3/2/2015
Amgen (AMGN) Release: Phase 3 Head-To-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis (Carfilzomib) Over Velcade (Bortezomib) In Patients With Relapsed Multiple Myeloma     3/2/2015
Portola Pharmaceuticals, Inc. Announces Full Results From Positive Phase 3 ANNEXA-R Study Demonstrating That Andexanet Alfa Rapidly And Significantly Reversed Anticoagulant Effect Of Factor Xa Inhibitor XARELTO     3/2/2015
CEL-SCI (CVM) Completes Key Milestone With Clearance To Conduct Phase 3 Trial In 21 Countries     3/2/2015
BioLineRx Ltd. Announces Regulatory Submission For Phase 2b Trial For Novel AML Consolidation Treatment     3/2/2015
Opsona Therapeutics Ltd. Commences Part B Of Phase II Study Of Blocking Toll-Like Receptor 2 In Extended Criteria Donor Renal Transplant Recipients At High Risk Of Early Graft Dysfunction     3/2/2015
Transition Therapeutics Inc. (TTH.TO) Announces Enrolment Completion Of ELND005 Phase 2 Clinical Study In Agitation And Aggression In Patients With Alzheimer's Disease     3/2/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Cancer Of The Fallopian Tube     3/2/2015
Acceleron Pharma Presents Encouraging Response Rates And Progression-Free Survival Data In Patients With Advanced Renal Cell Carcinoma At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium     3/2/2015
Alizé Pharma Launches Phase 2 Clinical Trial Of AZP-531 In Prader-Willi Syndrome     3/2/2015
Aldeyra Therapeutics (ALDX) Provides Update On NS2 Clinical Program     3/2/2015
Acasti Pharma Receives Full Data For Phase II TRIFECTA Trial     3/2/2015
Almac Discovery Initiates Phase 1 Study Of ALM201 For The Treatment Of Patients With Advanced Ovarian Cancer And Other Solid Tumours     3/2/2015
Pharmacyclics (PCYC) Release: In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody     3/2/2015
Alkermes plc (ALKS) Announces New Drug Candidate, ALKS 7119, For Treatment Of Alzheimer's Agitation, Depression And Other CNS Diseases     3/2/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation     3/2/2015
Society Of Interventional Radiology Release: Image-Guided Treatment Shown To Break The Migraine Cycle     3/2/2015
Society Of Interventional Radiology Release: Interventional Radiology Treatment Relieves Chronic Plantar Fasciitis     3/2/2015
Memorial Sloan-Kettering Cancer Center Snags Breakthrough Designation From the FDA     3/2/2015
Mast Therapeutics (MSTX) Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure     3/2/2015
ViaDerma To Initiate Upcoming Field Trial Of Comparison For Onychomycosis     3/2/2015
American Osteopathic Association Release: Pilot Project Finds Potential in Osteopathic Manipulative Treatment For Carpal Tunnel Syndrome     3/2/2015
Themis Bioscience’s Chikungunya Vaccine Study Results Published In The Lancet Infectious Diseases     3/2/2015
Children's Hospital of Philadelphia Release: New Genetic Syndrome Found, Arising From Errors In 'Master Switch' During Early Development     3/2/2015
NYU Langone Medical Center Release: Sleep-walking Neurons: Brain's GPS Never Stops Working - Even During Sleep     3/2/2015
Pernix Therapeutics, Inc. (PTX) Release: Nationwide Wake-Up Call: New Survey Reveals More Than Half Of Americans Are Unable To Sleep Throughout The Night     3/2/2015
Atara Biotherapeutics (ATRA) Release: FDA Grants Breakthrough Therapy Designation To Epstein-Barr Virus (EBV) Targeted T-Cells For Treatment Of EBV- Associated Lymphoproliferative Disease     3/2/2015
Editas Medicine Reports New Data Demonstrating Potential Of CRISPR/Cas9 Construct As Novel Gene Repair Mechanism     3/2/2015
Vexim Release: Excellent Long Term Performances Of Spinejack Supported By A 24-Month Follow-Up Clinical Study     3/2/2015
Genstar Capital L.P. Backed eResearch Technology Inc. (ERT) (ERES) To Acquire PHT Corporation     3/2/2015
ICON Completes Acquisition Of MediMedia Pharma Solutions     3/2/2015
Teva Pharmaceutical Industries (TEVA) Announces Sale Of Sellersville, PA Facility     3/2/2015
Mesa Labs (MLAB) Acquires Its UK And Germany Distribution Of Biological Indicators     3/2/2015
Intrexon Corporation To Acquire Okanagan Specialty Fruits     3/2/2015
Akili Interactive Labs Announces Clinical Collaboration Agreement With Autism Speaks' Affiliate DELSIA LLC     3/2/2015
Resilience And PsychoGenics Inc. Announce A Drug Discovery Partnership     3/2/2015
PharMerica Announces Wholesale Drug Distribution Agreement With Cardinal Health (CAH)     3/2/2015
Stand Up To Cancer Release: EHE International Joins Forces With Stand Up To Cancer And Genentech (RHHBY) To Raise Awareness, Stress Importance Of Supporting Research     3/2/2015
Suneva Medical Selects Crown Bioscience, Inc. To Co-Promote ReFissa     3/2/2015
Athersys, Inc. (ATHX) And Chugai Pharmaceutical Co., Ltd. (Japan) Enter License Agreement And Collaboration To Develop Multistem Cell Therapy For Ischemic Stroke In Japan     3/2/2015
Genmab A/S (GEN.CO) Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG (NVS) Is Now Effective     3/2/2015
Kite Pharma (KITE) Expands Its Research And Development Collaboration With The National Cancer Institute To Develop A Next Generation Of Cancer Immunotherapy Products For Solid Tumors     3/2/2015
Nanospeed Announces Global Distribution Partnership With Diasys Diagnostics Systems For Test4D     3/2/2015
Isis Pharmaceuticals, Inc. (ISIS) Earns $15 Million From GlaxoSmithKline (GSK) for Advancing ISIS-TTR Rx     3/2/2015
Crohn's and Colitis Foundation of America Release: Three Research Leaders Join Forces To Study Diet's Role In Inflammatory Bowel Diseases     3/2/2015
SCIEX And Labor Berlin Collaboration To Advance Forensic Testing     3/2/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015     3/2/2015
CSIRO Maintains Foundational Patent For RNAi Gene Silencing Technology After European Opposition     3/2/2015
VG Life Sciences, Inc. (VGLS) Granted Key Composition Of Matter Patent     3/2/2015
DelMar Pharmaceuticals Receives Notice Of Allowance Of Fourth U.S. Patent Covering Methods Of Use And Compositions For VAL-083     3/2/2015
Elder Pharmaceutical Ltd. Forays Into The Rs 800 Crore Nasal Inhaler Segment With Launch Of "Solo" Inhalers     3/2/2015
University of Maryland Release: Patent Awarded For Compounds That Inhibit Formation And Persistence Of Biofilms     3/2/2015
ImevaX Welcomes Kfw To Investor Syndicate In Second Closing Of Series A Financing     3/2/2015
Champions Oncology, Inc. (CSBR) Extends Convertible Debt Financing     3/2/2015
Actavis (ACT) Announces Proposed Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN)     3/2/2015
Tandem Diabetes Care Announces Exercise Of Option To Purchase Additional Shares In Underwritten Public Offering Of Common Stock     3/2/2015
Merus Labs International Inc. Announces Settlement Of Canadian Patent Litigation     3/2/2015
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Amendment To Loan Agreement     3/2/2015
Celldex (CLDX) Announces Exercise Of Underwriters' Option To Purchase Additional Shares     3/2/2015
Cesca Therapeutics Receives Notice Of Non-Compliance With Nasdaq Listing Rule     3/2/2015
RainDance Technologies Files Registration Statement For Proposed IPO     3/2/2015
Loxo Oncology (LOXO) Announces 2015 Program Guidance And Reveals Selected Pipeline Programs     3/2/2015
Array BioPharma, Inc. (ARRY) Announces Completion Of Binimetinib And Encorafenib Transactions     3/2/2015
ImmunoCellular Therapeutics, Ltd (IMUC) To Report 2014 Financial Results On March 9, 2015; A Business Update Conference Call And Webcast Is Scheduled For March 12, 2015     3/2/2015
InMed Pharmaceuticals To Present Investor Webcast March 5     3/2/2015
Roche (RHHBY) Extends Tender Offer For Foundation Medicine, Inc. (FMI)     3/2/2015
Karolinska Development AB Confirms Full Payment In The Rights Issue Of Convertibles     3/2/2015
DNAnexus, Inc. Powers Intermountain Cancer Genomics To Deliver Precision Medicine To Cancer Patients     3/2/2015
DNAnexus, Inc. Enables Seamless Assembly Of Pacific Biosciences (PACB) Data For J. Craig Venter Institute Genome     3/2/2015
Catalent, Inc. Announces Launch Of Secondary Public Offering Of Common Stock     3/2/2015
EXACT Sciences Corporation (EXAS) Grants Inducement Restricted Stock Unit Awards To New Employees     3/2/2015
Hemispherx Biopharma (HEB) Announces The Completion Of The Newly Upgraded Alferon Facility: Commercial Production Of Alferon Is In The Final Stage Integrating Continuous Flow Manufacturing Technology     3/2/2015
The Children's Hospital of Philadelphia Opens Pediatric Urgent Care Center In Chalfont, Pa.     3/2/2015
Pacific Biosciences (PACB) Enables Reference-Quality De Novo Human Genome Assemblies     3/2/2015
Lehvoss North America Introduces New Generation Of PTFE-Modified Compounds     3/2/2015
Allergy Therapeutics plc Release: Interim Report For The Six Months Ended 31 December 2014     3/2/2015
Asterias BiotherapeuticsTo Report Fourth Quarter And Full Year 2014 Results On March 10, 2015     3/2/2015
Antibe Therapeutics Inc. (ATE.V) Reports Q3 2015 Interim Financial And Operating Results And Director Resignation     3/2/2015
Acceleron Pharma Reports Fourth Quarter And Year Ended 2014 Financial And Operational Results     3/2/2015
BIND Therapeutics (BIND) To Report Fourth Quarter And Year-End 2014 Financial Results On March 11, 2015     3/2/2015
BioScrip (BIOS) Reports Fourth Quarter 2014 Financial Results     3/2/2015
Chimerix (CMRX) To Announce Fourth Quarter And Year End 2014 Financial Results On March 6, 2015     3/2/2015
Endocyte, Inc. (ECYT) Reports Fourth Quarter And Year End 2014 Financial Results And Provides Clinical Updat     3/2/2015
Second Quarter Results - Fiscal 2015 - Ergoresearch Inc. (ERG) Reports Its Results For The Quarter Ended December 31, 2014     3/2/2015
Endo International (ENDP) Reports Fourth Quarter And Full Year 2014 Financial Results     3/2/2015
ESSA Pharma Inc. Reports First Quarter 2015 Financial Results     3/2/2015
Getinge Annual Report 2014     3/2/2015
Horizon Pharma plc.  (HZNP) Announces Fourth Quarter And Full Year 2014 Financial Results And Raises Guidance For 2015     3/2/2015
Intercept Pharmaceuticals (ICPT) Announces 2014 Financial Results     3/2/2015
Lexicon Pharmaceuticals, Inc. (LXRX) To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015     3/2/2015
Portola Pharmaceuticals, Inc. Reports Fourth Quarter And Year-End 2014 Financial Results And Provides Corporate Update     3/2/2015
PharMerica Reports Fourth Quarter And Full Year 2014 Results     3/2/2015
Incyte Corporation (INCY) Appoints Steven H. Stein, MD As Chief Medical Officer     3/2/2015
diaDexus Announces Appointment Of Leone Patterson As Chief Financial Officer     3/2/2015
EyeGate Pharma Names Michael B. Raizman, MD, Consulting Chief Medical Officer     3/2/2015
Sundia Announces Retirement Of CEO Dr. Chen Chen, Dr. Jim Li Named As Successor     3/2/2015
NGM Announces Expansion Of Management Team     3/2/2015
Dominique Laymand Is Appointed As Ipsen (IPN.PA)’s Senior Vice President, Chief Ethics And Compliance Officer     3/2/2015
Macrocure (MCUR) Hires Dr. Ramesh Tharuvai, Ph.D. As Vice President, Operations     3/2/2015
Chamaeleo Pharma Appoints Han Van ‘t Klooster As Vice President Of Commercial Operations     3/2/2015
Dr. David Rimm Joins Biocept, Inc. (BIOC) As A Scientific Advisor     3/2/2015
Celator Pharmaceuticals, Inc. Appoints Jean-Pierre Bizzari To Board Of Directors     3/2/2015
CytomX Therapeutics, Inc. Expands Scientific And Clinical Advisory Boards With Leading Experts In Cancer Immunotherapy And Antibody Drug Conjugates     3/2/2015
New Members of Medivir AB (MVRBF)’s Management Group     3/2/2015
Radius (RDUS) Appoints Former Novartis AG (NVS) Executive Tony Rosenberg To Board Of Directors     3/2/2015
Meningitis Angels Testify At CDC For Stronger Recommendations On Men B Vaccines     3/2/2015
Forte Research Systems, Inc., A Top Resource For Clinical Research Professionals     3/2/2015
DaVita Inc. (DVA) Encourages People To Get To Know Their Kidneys During National Kidney Month     3/2/2015
University of Michigan Health System Release: CHAMPs For Mott Gala And Golf Tournament To Benefit U-M C.S. Mott Children's Hospital Scheduled For May 15-18, 2015     3/2/2015
DATATRAK International, Inc. (DATA) Challenges The Industry At Outsourcing In Clinical Trials Southeast     3/2/2015
MRC Technology Launches Respiratory "Call For Targets"     3/2/2015
International Myeloma Foundation Declares March "Myeloma Awareness Month"     3/2/2015
The National Parkinson Foundation Invests In The Future Of Parkinson's Research     3/2/2015
21 Years Of Debate: The Pharmaceutical Industry Convenes At The Economist Events' Pharma Summit 2015 To Discuss The Dawn Of A New Era For The Industry     3/2/2015
Novo Nordisk A/S (NVO),Takeda (TKPYY), Servier, Celgene (CELG) Among Top Sponsors Rated By Investigative Sites In New CenterWatch Inc. Survey     3/2/2015
Atossa Genetics, Inc. (ATOS) Announces That Its Subsidiary The National Reference Laboratory For Breast Health Has Received Accreditation From College of American Pathologists     3/2/2015
Corbus Pharmaceuticals, Inc. Observes Annual Rare Disease Day     3/2/2015
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For December 31, 2014     3/2/2015
Cytokinetics, Inc. (CYTK) Joins Global Movement To Raise Awareness For Rare Diseases     3/2/2015
Aegerion (AEGR) Observes Rare Disease Day     3/2/2015
WuXi PharmaTech Co., Ltd. Congratulates TaiMed Biologics On Receiving Breakthrough Therapy Designation From U.S. FDA     3/2/2015
BioLife Solutions, Inc. (BLFS.OB) Wins Washington State 2015 Silver Award For Achievement In Medical Technology From Seattle Business Magazine     3/2/2015
Dr. Julie Brahmer, MD, Named March LUNGevity Hero For Research In Groundbreaking Field Of Immunotherapy     3/2/2015
Lonza Inc. Hosts 1st Global Endotoxin Testing Summit     3/2/2015
Charles River Laboratories To Present At March Investor Conferences     3/2/2015
ISPE To Release Preliminary Data From Quality Metrics Pilot At Summit     3/2/2015
Compugen Ltd. (CGEN) To Present At Two Oncology Conferences In March     3/2/2015
Cerulean Pharma Inc. (CERU) To Present At Two Upcoming Conferences     3/2/2015
Viewics, Inc. CEO Dhiren Bhatia To Present At First Annual G2 Lab Revolution Conference     3/2/2015
Synthetic Biologics, Inc. (SYN) Announces Two Poster Presentations Of Novel Monoclonal Antibody Combination For Treatment Of Whooping Cough (Pertussis) At ECCMID 2015     3/2/2015
Findings To Be Presented At Annual Scientific Session Of The American College of Cardiology About An Additional Potential Reversal Strategy For And Real-World Safety Performance Of XARELT     3/2/2015
Pfenex (PFNX)To Present At The 2015 Barclays Global Healthcare Conference     3/2/2015
MediGene AG (MDGEF.PK) To Participate In Three Upcoming International Conferences     3/2/2015
Life Science Association of Manitoba Release: National Biotechnology CEO Presenting At Local Life Science Gala     3/2/2015
Veeva Systems, Inc. To Participate In Upcoming Investor Conferences     3/2/2015
Ohr Pharmaceutical (OHRP) Announces Additional Positive Anatomic Data From The OHR-102 IMPACT Study Interim Analysis Presented At Annual Macula Society Meeting     3/2/2015
Positive Bioavailability Studies Of RedHill Biopharma Ltd. (RDHL)'s BEKINDA To Be Presented At The 2015 American Society For Clinical Pharmacology And Therapeutics (ASCPT) Meeting     3/2/2015
Endocyte, Inc. (ECYT) To Present Data On EC1456 And EC1169 At The International Congress On Targeted Anticancer Therapies In Paris     3/2/2015
TRACON Pharmaceuticals, Inc. (TCON) Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta (Axitinib) At The ASCO 2015 Genitourinary Cancers Symposium     3/2/2015
TONIX Pharmaceuticals, Inc. (TNXP) To Present At The 8th Annual European Life Sciences CEO Forum     3/2/2015
TG Therapeutics, Inc. (MHA) To Present At The Cowen and Company 35th Annual Health Care Conference     3/2/2015
Lion Biotechnologies, Inc. To Present At Cowen and Company's 35th Annual Healthcare Conference     3/2/2015
Advaxis, Inc. To Present At The Cowen and Company 35th Annual Health Care Conference     3/2/2015
Immunocore Limited To Present At Cowen and Company 35th Annual Health Care Conference     3/2/2015
The Medicines Company (MDCO) To Participate In Cowen and Company 35th Annual Health Care Conference     3/2/2015
Leidos To Present At The J.P. Morgan Aviation, Transportation And Industrials Conference     3/2/2015
Dynavax Technologies Corporation (DVAX) To Present At Cowen and Company 35th Annual Health Care Conference     3/2/2015
Tokai Pharmaceuticals (TKAI) To Present At The Cowen and Company 35th Annual Health Care Conference     3/2/2015
Merck & Co. (MRK) To Present At The 35th Annual Cowen and Company Health Care Conference     3/2/2015
GlobeImmune, Inc. (GBIM) To Present At The 27th Annual ROTH Conference     3/2/2015
GenVec Inc. (GNVC) To Present At The 27th Annual ROTH Conference     3/2/2015
Galmed PharmaceuticalsTo Present At The 27th Annual ROTH Conference     3/2/2015
Neptune Technologies & Bioressources Inc. To Present At 27th Annual Roth Conference     3/2/2015
Agile Therapeutics, Inc. To Present At The 27th Annual ROTH Conferencea     3/2/2015
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The ROTH Capital Partners 27th Annual Growth Stock Conference     3/2/2015
Relypsa, Inc. (RLYP) To Present At 27th Annual ROTH Conference     3/2/2015
Week In Review: Eddingpharm Pays $169 Million For China Rights To Omega-3 Drug     3/2/2015
BioSpace (DHX) Temperature Poll: Do You Think Sanofi (SAN.PA)'s CEO Salary is Too High?     3/2/2015

Career Tips
HR Exec Reveals In-Demand Jobs at MyoKardia     2/19/2015
Pfizer (PFE) Buy Means Jobs: Make Sure Your References Are an Asset     2/19/2015
7 Job Search Sins     2/19/2015
5 Critical Reference Trends for 2015: Advice From HR Professionals     2/19/2015
5 Perfect Opportunities to Send a Thank You Note During Your Job Search     2/19/2015
Snag a Job: Here's How CSL Behring Makes Hiring Decisions     2/6/2015
Does Changing Ethnic Names on Resumes Improve Getting Hired?     2/5/2015
The One Empty Word to Avoid in a Job Interview     2/5/2015
10 Sure Things of a Successful Resume     2/5/2015
How to Create a Captivating Cover Letter     2/5/2015
Where Does Sanofi (SAN.PA) Find the Best Employees?     1/23/2015
Genentech (RHHBY) Reveals Their Greatest Source of Who They Hire     1/22/2015
6 Rules Every Biotech Job Seeker Should Know     1/22/2015
6 Things You Must Know When Working With Recruiters, HR, and Hiring Managers     1/22/2015
The Ultimate Secret of Acing Behavioral Interviews     1/22/2015

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->